[HTML][HTML] HTLV-1 HBZ viral protein: a key player in HTLV-1 mediated diseases
M Baratella, G Forlani, RS Accolla - Frontiers in microbiology, 2017 - frontiersin.org
Human T cell leukemia virus type 1 (HTLV-1) is an oncogenic human retrovirus that has
infected 10–15 million people worldwide. After a long latency, 3–5% of infected individuals …
infected 10–15 million people worldwide. After a long latency, 3–5% of infected individuals …
HTLV-1 HBZ Viral Protein: A Key Player in HTLV-1 Mediated Diseases
M Baratella, G Forlani… - Frontiers in …, 2017 - pubmed.ncbi.nlm.nih.gov
Human T cell leukemia virus type 1 (HTLV-1) is an oncogenic human retrovirus that has
infected 10-15 million people worldwide. After a long latency, 3-5% of infected individuals …
infected 10-15 million people worldwide. After a long latency, 3-5% of infected individuals …
[HTML][HTML] HTLV-1 HBZ Viral Protein: A Key Player in HTLV-1 Mediated Diseases
M Baratella, G Forlani, RS Accolla - Frontiers in Microbiology, 2017 - ncbi.nlm.nih.gov
Human T cell leukemia virus type 1 (HTLV-1) is an oncogenic human retrovirus that has
infected 10–15 million people worldwide. After a long latency, 3–5% of infected individuals …
infected 10–15 million people worldwide. After a long latency, 3–5% of infected individuals …
HTLV-1 HBZ Viral Protein: A Key Player in HTLV-1 Mediated Diseases
M Baratella, G Forlani, RS Accolla - 2017 - agris.fao.org
Human T cell leukemia virus type 1 (HTLV-1) is an oncogenic human retrovirus that has
infected 10–15 million people worldwide. After a long latency, 3–5% of infected individuals …
infected 10–15 million people worldwide. After a long latency, 3–5% of infected individuals …
HTLV-1 HBZ viral protein: A key player in HTLV-1 mediated diseases
M Baratella, G Forlani, R Accolla - FRONTIERS IN …, 2017 - irinsubria.uninsubria.it
Human T cell leukemia virus type 1 (HTLV-1) is an oncogenic human retrovirus that has
infected 10–15 million people worldwide. After a long latency, 3–5% of infected individuals …
infected 10–15 million people worldwide. After a long latency, 3–5% of infected individuals …
HTLV-1 HBZ Viral Protein: A Key Player in HTLV-1 Mediated Diseases.
M Baratella, G Forlani, RS Accolla - Frontiers in Microbiology, 2017 - europepmc.org
Human T cell leukemia virus type 1 (HTLV-1) is an oncogenic human retrovirus that has
infected 10–15 million people worldwide. After a long latency, 3–5% of infected individuals …
infected 10–15 million people worldwide. After a long latency, 3–5% of infected individuals …
[引用][C] HTLV-1 HBZ Viral Protein: A Key Player in HTLV-1 Mediated Diseases
M Baratella, G Forlani, RS Accolla - Frontiers in Microbiology, 2017 - cir.nii.ac.jp
HTLV-1 HBZ Viral Protein: A Key Player in HTLV-1 Mediated Diseases | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
[PDF][PDF] HTLV-1 HBZ Viral Protein: A Key Player in HTLV-1 Mediated Diseases
M Baratella, G Forlani, RS Accolla - Front. Microbiol. 8: 2615. doi …, 2017 - academia.edu
Human T cell leukemia virus type 1 (HTLV-1) is an oncogenic human retrovirus that has
infected 10–15 million people worldwide. After a long latency, 3–5% of infected individuals …
infected 10–15 million people worldwide. After a long latency, 3–5% of infected individuals …
[PDF][PDF] HTLV-1 HBZ Viral Protein: A Key Player in HTLV-1 Mediated Diseases
M Baratella, G Forlani, RS Accolla - Front. Microbiol. 8: 2615. doi …, 2017 - academia.edu
Human T cell leukemia virus type 1 (HTLV-1) is an oncogenic human retrovirus that has
infected 10–15 million people worldwide. After a long latency, 3–5% of infected individuals …
infected 10–15 million people worldwide. After a long latency, 3–5% of infected individuals …